30 Participants Needed

Vibrotactile Stimulation for Stroke Recovery

LA
RA
EA
KD
Overseen ByKimberly D Bassindale, DPT
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how vibrotactile stimulation (a type of touch-based feedback) can help stroke survivors regain better arm control. It focuses on individuals who have lost some sense of body position (proprioception) after a stroke, specifically aiding tasks like reaching or simulating drinking from a glass. Researchers will test two training approaches: one focusing on complex tasks and the other on a gradual increase in difficulty. This trial suits stroke survivors who can grip objects and have mild-to-moderate arm movement challenges, with some sensation remaining in their arm or thigh. As an unphased trial, it offers participants a unique opportunity to contribute to innovative research that could enhance rehabilitation techniques for stroke survivors.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using certain antibiotics or agents that affect neuromuscular function.

What prior data suggests that this vibrotactile stimulation is safe for stroke recovery?

Research has shown that using gentle vibrations on the arm is safe for people who have had a stroke. In one study, a wearable device called the VTS Glove delivered these vibrations to the affected arm. The study found that participants tolerated the treatment well, and it helped reduce muscle stiffness in stroke survivors.

Another study supported these findings, showing that daily use of the VTS Glove reduced muscle stiffness and tightness. This indicates that the vibrations not only alleviated stiffness but were also safe for daily use.

Overall, these findings suggest that gentle vibrations are a safe and well-tolerated option for people recovering from a stroke.12345

Why are researchers excited about this trial?

Researchers are excited about vibrotactile stimulation for stroke recovery because it offers a novel approach to rehabilitation. Unlike traditional therapies that might rely on physical exercises alone, this method uses vibrotactile feedback to guide patients in performing reaching tasks. This feedback acts like a sensory guide, potentially enhancing motor learning and recovery by providing immediate, tactile cues. By integrating this unique feedback mechanism, the technique could accelerate improvements in patients' motor skills and offer a more interactive and engaging rehabilitation process.

What evidence suggests that vibrotactile stimulation is effective for stroke recovery?

Research has shown that vibrotactile stimulation, such as the VTS Glove, can enhance movement in stroke patients. In this trial, participants will receive vibrotactile stimulation as part of either whole task training or progressive training. Patients using this technology demonstrated noticeable improvements in sensation and reduced muscle tightness. One study found that this type of stimulation improved muscle tone more effectively than Botox injections, which are often used to treat muscle stiffness. This method guides movement by providing sensory feedback, which is especially beneficial for those who have lost some sensation. Overall, early findings suggest this approach could be promising for stroke recovery.15678

Who Is on the Research Team?

RA

Robert A Scheidt, PhD

Principal Investigator

Marquette University

Are You a Good Fit for This Trial?

This trial is for stroke survivors with mild-to-moderate arm impairment, who can feel touch in the affected arm or thigh and have a minimal ability to extend their wrist. They must be at least 6 months post-stroke from an MCA event, able to consent and follow instructions, and have specific proprioceptive deficits. People with bleeding disorders, muscle diseases like ALS or myasthenia gravis, epilepsy, severe psychiatric conditions, pacemakers or significant heart issues cannot join.

Inclusion Criteria

I can slightly bend my wrist upwards.
I had a stroke but can still stabilize and grip objects.
I can feel touch in my arm or thigh on the same side as my lesion.
See 4 more

Exclusion Criteria

You have a history of other mental health conditions like schizophrenia.
I am not currently using drugs that affect muscle function.
I have a tumor inside my brain.
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Baseline Testing

Participants complete baseline tests of cognitive performance and sensorimotor impairment

3 days
3 visits (in-person)

Training

Participants undergo 20 sessions of training with supplemental kinesthetic feedback to improve motor control

20 days
20 visits (in-person)

Post-Training Assessment

Participants are re-tested on their capability to use a 3-DOF vibrotactile display for reach-to-grasp actions

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after training

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Vibrotactile stimulation
Trial Overview The study tests if vibrotactile stimulation—a type of sensory feedback—can help improve arm function after stroke. Thirty participants will try this method while doing tasks like reaching out or simulating drinking from a glass to see if it enhances motor control.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Stroke Cohort - Whole Task TrainingExperimental Treatment1 Intervention
Group II: Stroke Cohort - Progressive TrainingExperimental Treatment1 Intervention

Vibrotactile stimulation is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Vibrotactile stimulation for:
🇪🇺
Approved in European Union as Vibrotactile stimulation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Marquette University

Lead Sponsor

Trials
68
Recruited
202,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Medical College of Wisconsin

Collaborator

Trials
645
Recruited
1,180,000+

Published Research Related to This Trial

In a study involving 16 chronic stroke survivors, the VTS Glove, which provides vibrotactile stimulation, significantly improved tactile perception and reduced spasticity in the affected hand over an 8-week period.
Participants using the VTS Glove also experienced increased voluntary finger flexion and improved range of motion in the elbow and shoulder, suggesting that wearable stimulation devices can enhance hand function in stroke rehabilitation.
Wearable vibrotactile stimulation for upper extremity rehabilitation in chronic stroke: clinical feasibility trial using the VTS Glove.Seim, CE., Wolf, SL., Starner, TE.[2021]
A pilot study demonstrated that applying subthreshold tactile sensory noise, like mechanical vibration, to the wrist significantly improved hand dexterity and pinch strength in chronic stroke survivors with sensory deficits.
The improvements in motor function suggest that this method may enhance neuronal connections in the sensoriomotor cortex, indicating potential for a simple wristband device to aid rehabilitation both in clinics and at home.
Effect of remote sensory noise on hand function post stroke.Seo, NJ., Kosmopoulos, ML., Enders, LR., et al.[2020]
The study developed a wireless wearable device that provides real-time vibrotactile feedback to assist in motor learning for bilateral reaching motions, which is particularly useful for at-home rehabilitation after a stroke.
Preliminary results from one hemiparetic stroke survivor and one healthy subject showed that vibrotactile feedback effectively improved motion symmetry and altered reaching trajectories, suggesting its potential for enhancing motor learning in both populations.
A wearable vibrotactile device for upper-limb bilateral motion training in stroke rehabilitation: A case study.Hung, CT., Croft, EA., Van der Loos, HF.[2020]

Citations

Wearable vibrotactile stimulation for upper extremity ...Participants using the VTS Glove showed significantly improved Semmes-Weinstein monofilament exam results, reduction in Modified Ashworth ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37706171/
Relief of post-stroke spasticity with acute vibrotactile ...Objective: Determine which vibrotactile stimulation approach is most effective at reducing spastic hypertonia among post-stroke patients.
Daily Vibrotactile Stimulation Exhibits Equal or Greater ...Study design. The study was a prospective, 2-arm intervention study using the VTS Glove for treatment of spastic hypertonia in patients with chronic stroke.
Daily Vibrotactile Stimulation Exhibits Equal or Greater ...The VTS Glove was associated with greater average improvement in spasticity and hypertonia than Botox injection.
Vibrotactile Motion Guidance for Stroke RehabilitationMultimodal stimuli for trajectory correction benefited the patients but there were also differences in their tactile perception. These patient- ...
Vibrotactile Stimulation for Upper-Extremity Stroke ...Also called a data safety and monitoring board, or DSMB. Early Phase 1 ... Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation.
Daily vibrotactile stimulation from a wearable device exhibits ...The VTS Glove, which delivers mobile or home-based upper extremity vibrotactile stimulation in stroke survivors, provides reduction of spasticity and ...
Relief of post-stroke spasticity with acute vibrotactile ...Cutaneous vibrotactile stimulation of the hand provides significant reductions in spastic hypertonia, compared to muscle stimulation.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security